Vischer with Relief on NeuroX Group acquisition
Vischer advised Relief, now MindMaze Therapeutics Holding, in connection with its acquisition of all shares in NeuroX Group, against issuance of new MMTX shares to complete their business combination by way of reverse merger.
The new MMTX shares debuted on the SIX Swiss Exchange on 15 December 2025.
The Vischer team
Partner Robert Bernet (corporate/M&A and banking & finance, pictured) led the Vischer team on the matter, working alongside counsel Peter Kühn (corporate/M&A and banking & finance), managing associates Thomas Steiner-Krizaj (corporate/M&A) and Christian Schneiter (banking & finance), junior associate Hannah Everett (corporate/M&A and banking & finance), partner Christoph Niederer (tax) and managing associate Patrik Fisch (tax).
